Over-the-counter triptans--making the switch.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004347:Drug Interactions; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence / Q000639:trends*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D004366:Nonprescription Drugs / Q000009:adverse effects / Q000145:classification* / Q000627:therapeutic use; D023303:Oxazolidinones / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D010594:Pharmacies / Q000331:legislation & jurisprudence* / Q000639:trends; D017366:Serotonin Receptor Agonists / Q000009:adverse effects / Q000145:classification* / Q000627:therapeutic use; D018170:Sumatriptan / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D014363:Tryptamines; D006113:United Kingdom
D004366:Nonprescription Drugs; D023303:Oxazolidinones; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C089750:zolmitriptan; D018170:Sumatriptan